Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adverse Effects of Domperidone: Prolonged QuesT for Knowledge?

Literature DB >> 27714509

Adverse Effects of Domperidone: Prolonged QuesT for Knowledge?

Mohammad Bashashati¹, Irene Sarosiek¹, Tariq Siddiqui², Richard W McCallum³.

Abstract

Entities: Chemical

Mesh：

Substances：
Domperidone

Year: 2016 PMID： 27714509 DOI： 10.1007/s10620-016-4333-9

Source DB: PubMed Journal: Dig Dis Sci ISSN： 0163-2116 Impact factor: 3.199

× No keyword cloud information.

16 in total

1. Domperidone versus metoclopramide in the treatment of diabetic gastroparesis.

Authors: D L Dumitrascu; M Weinbeck
Journal: Am J Gastroenterol Date: 2000-01 Impact factor: 10.864

2. Domperidone and ventricular arrhythmia or sudden cardiac death: a population-based case-control study in the Netherlands.

Authors: Charlotte van Noord; Jeanne P Dieleman; Gerard van Herpen; Katia Verhamme; Miriam C J M Sturkenboom
Journal: Drug Saf Date: 2010-11-01 Impact factor: 5.606

3. In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs.

Authors: Marie L De Bruin; Pim N J Langendijk; Richard P Koopmans; Arthur A M Wilde; Hubert G M Leufkens; Arno W Hoes
Journal: Br J Clin Pharmacol Date: 2006-07-21 Impact factor: 4.335

4. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis.

Authors: I Soykan; I Sarosiek; R W McCallum
Journal: Am J Gastroenterol Date: 1997-06 Impact factor: 10.864

5. Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study.

Authors: Catherine B Johannes; Cristina Varas-Lorenzo; Lisa J McQuay; Kirk D Midkiff; Daniel Fife
Journal: Pharmacoepidemiol Drug Saf Date: 2010-09 Impact factor: 2.890

6. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis.

Authors: D Patterson; T Abell; R Rothstein; K Koch; J Barnett
Journal: Am J Gastroenterol Date: 1999-05 Impact factor: 10.864

7. Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study.

Authors: Hung-Lin Chen; Fei-Yuan Hsiao
Journal: Pharmacoepidemiol Drug Saf Date: 2015-06-22 Impact factor: 2.890

8. Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis.

Authors: C E Farup; N K Leidy; M Murray; G R Williams; L Helbers; E M Quigley
Journal: Diabetes Care Date: 1998-10 Impact factor: 19.112

9. Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group.

Authors: D Silvers; M Kipnes; V Broadstone; D Patterson; E M Quigley; R McCallum; N K Leidy; C Farup; Y Liu; A Joslyn
Journal: Clin Ther Date: 1998 May-Jun Impact factor: 3.393